Data / Form D filings / Toby, Inc.
Toby, Inc.: Form D filings
Toby, Inc., a biotechnology company in Wilmington, DE, filed 2 Form D notices with the SEC in 2025. The latest, on July 15, 2025, reports $814,990 sold of a $814,990 offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1207 DELAWARE AVE, Wilmington, DE, 19806
- Phone
- (203) 280-3252
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2053723
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | New notice | $814,990 | $814,990 | 7 | May 30, 2025 | sec.gov | |
| Feb 4, 2025 | New notice | $600,000 | $600,000 | 4 | Dec 16, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dragan Sebisanovic | Executive Officer, Director | |
| Mark November | Director | |
| Matthew Laskowski | Executive Officer, Director | |
| Joseph Hanssen | Director | |
| John Legget | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Toby, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.